Scientists warn diabetes patients may have increased bleeding from taking aspirin
LONDON Scientists from the University of Dundee have released a report that states taking aspirin may lead to increased internal bleeding and other complications in diabetes patients.
Many people take aspirin daily to help reduce the risk of heart attack. But, scientists have concluded that taking aspirin doesn’t mitigate the risk of heart attack for diabetes patients, unless they already had heart disease.
Following an eight-year study that followed 1,276 diabetes patients who took aspirin, a placebo or an antioxidant to help prevent heart disease, researchers concluded that aspirin should be taken only by patients already dealing with heart disease or who have suffered a stroke.
Advertising council makes recommendations on Constellation Wines’ dietary claims
NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Tuesday determined that Constellation Wines U.S./PolyPhenolics provided reasonable support for certain performance claims made for the company’s dietary supplement MegaNatural-BP, but recommended the company discontinue certain claims to avoid consumer confusion.
NAD was concerned that that the claim “Provide relief with half the cost, half the dose,” did not clearly identify the object of the comparison and suggested that consumers with high blood pressure could replace prescribed medication with a supplement.
NAD recommended that the advertiser discontinue the claim, “Provide relief with half the cost, half the dose and half the time” but noted that the advertiser can continue to discuss the differences between MegaNatural-BP and the competing Antigen Converting Enzyme (ACE) inhibitors which take 4-6 weeks of regular supplementation to work.
NAD recommended that to avoid the potential for any consumer confusion, and consistent with the findings of the studies on which it relies, the advertiser clearly and conspicuously disclose that MegaNatural-BP could be used as a part of a lifestyle management program for people with prehypertension and metabolic syndrome, and clearly state that consumers should “Consult your doctor before taking MegaNatural-BP.”
The company, in its advertiser’s statement, said it “understands NAD’s decision as written and appreciates your thorough and well-explained rationale. Polyphenolics agrees to modify its advertising as recommended.”
Congressman ask for review of Bayer aspirin heart health claims
WASHINGTON Two Michigan democrats have singled out Bayer’s marketing of its Aspirin with Heart Advantage, a combination product that includes a dietary supplement, that appears to go against a Food and Drug Administration’s request not to advertise such products, said House of Representatives Energy and Commerce Chairman John Dingell, according to a Reuters report published Tuesday.
Dingell, along with Rep. Bart Stupak, fired off two letters suggesting that the supplement/analgesic combination product might need FDA approval—one to Bayer and the other to Health and Human Services secretary Michael Leavitt. HHS oversees the FDA.